Showing results (1561-1570 of 1,676) with videos related to

Sort By:
Pageof 168
Msystems|June 22, 2021
Insights into the Cultured Bacterial Fraction of CoralsMichael Sweet, Helena Villela, Tina Keller-Costa, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 10, 2025
Increasing representation of Asian American, Native Hawaiian, and Pacific Islander communities in aging, dementia, and caregiving research: An update from the CARE registryJoshua D Grill, Janice Y Tsoh, Bora Nam, et al.
Angewandte Chemie (International Ed. in English)|November 9, 2018
Identification and Directed Development of Non-Organic Catalysts with Apparent Pan-Enzymatic Mimicry into Nanozymes for Efficient Prodrug ConversionRaoul Walther, Anna K Winther, Anne Sofie Fruergaard, et al.
Journal of Environmental Management|March 23, 2023
Rapid prototyping for quantifying belief weights of competing hypotheses about emergent diseasesEllen P Robertson, Daniel P Walsh, Julien Martin, et al.
The Journal of Infectious Diseases|January 13, 2012
Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infectionJ Guergnon, C Dalmasso, P Broet, et al.
Nucleic Acids Research|November 11, 2008
The UCSC Genome Browser Database: update 2009R M Kuhn, D Karolchik, A S Zweig, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 6, 2026
Impact of partial- to full-support escalation with microaxial flow pumps prior to durable left ventricular assist device implantationDaniel Lewin, Gaik Nersesian, Sebastian V Rojas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanomaKam Fai Tse, Michael Jeffers, Vincent A Pollack, et al.
Journal of Medicinal Chemistry|May 19, 2012
A selective, orally bioavailable 1,2,4-triazolo[1,5-a]pyridine-based inhibitor of Janus kinase 2 for use in anticancer therapy: discovery of CEP-33779Benjamin J Dugan, Diane E Gingrich, Eugen F Mesaros, et al.
Cancer Research|February 21, 2006
Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugatesChe-Leung Law, Kristine A Gordon, Brian E Toki, et al.
Pageof 168